Nuwellis (NUWE) Q2 FY26 earnings call

Nuwellis delivered strong Q2 FY26 results, driven by robust U.S. revenue growth and significant gross margin expansion, while strategically investing in commercial expansion and product development. The company is focused on increasing Aquadex utilization, expanding its pediatric and adult critical care presence, and advancing its cardiorenal platform, supported by recent financing to strengthen its balance sheet.